LIPOPROTEIN(A)
Clinical trials for LIPOPROTEIN(A) explained in plain language.
Never miss a new study
Get alerted when new LIPOPROTEIN(A) trials appear
Sign up with your email to follow new studies for LIPOPROTEIN(A), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to tackle stubborn heart risk factor
Disease control Recruiting nowThis Phase 2 trial tests an experimental drug called MK-7262, alone or with another drug called enlicitide, in 750 adults with high levels of lipoprotein(a) – a genetic risk factor for heart disease. The study compares these drugs to a placebo to see if they can safely lower both…
Matched conditions: LIPOPROTEIN(A)
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug targets hidden heart risk in people with high lp(a)
Disease control Recruiting nowThis study tests a drug called lepodisiran in 252 adults with high levels of Lp(a), a protein linked to heart disease. Participants must have heart disease or be at risk for a first heart event. The drug is given as an injection and compared to a placebo to see if it reduces plaq…
Matched conditions: LIPOPROTEIN(A)
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
AI-Powered heart scans could predict heart attacks before they strike
Knowledge-focused Recruiting nowThis observational study will enroll 10,000 adults who are already scheduled for a cardiac CT scan. Researchers will use artificial intelligence to analyze the scans, looking for subtle signs of dangerous plaque that might predict future heart attacks. Participants will also give…
Matched conditions: LIPOPROTEIN(A)
Sponsor: University of Galway • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC